Featured Interview: CEO John Poss of GB Sciences, Inc. (OTCQB: GBLX)

Featured Interview: CEO John Poss of GB Sciences, Inc. (OTCQB: GBLX)

   CEO John Poss of GB Sciences, Inc. (OTCQB: GBLX), rejoins Stock Day and gives an update on the companies background, upcoming clinical trial, and plans for growth in 2018.


The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information. 

Close Menu